Table 1.

CONS of rechallenging with immune checkpoint inhibitors

1Recurrence of AKI
2Potential RRT dependency
3Increased hospitalizations
4Accelerated progression to severe CKD
5Increased health care utilization
6Risk of irAE in other organs
  • irAE, immune-related adverse effects; RRT, renal replacement therapy.